Myovant Sciences and Pfizer Receive U.S. FDA Approval of

Data from the Phase 3 SPIRIT program showed MYFEMBREE reduced menstrual pain and non-menstrual pelvic pain in premenopausal women with endometriosis, and a...

Related Keywords

United Kingdom ,California ,United States ,Switzerland ,San Francisco ,Ukraine ,American ,Reprod Genet ,Uneek Mehra ,James Rusnak ,Linda Giudice ,Arjona Ferreira ,Juan Camilo Arjona Ferreira ,University Of California ,Linkedin ,Twitter ,Adamson ,Pfizer ,Sumitomo Pharma Co Ltd ,Pfizer Inc ,Facebook ,Program Steering Committee ,Myovant Sciences Forward ,Effect On Other Laboratory ,American Society For Reproductive Medicine ,Myovant Sciences ,European Commission ,Drug Administration ,Women Health ,Global Product Development ,Exchange Commission ,Myovant Sciences Contacts ,Youtube ,Corporate Communications ,Myovant Sciences Inc ,Healthcare Products Regulatory Agency ,Sumitovant Biopharma Ltd ,Chief Medical Officer ,Senior Vice President ,Chief Development Officer ,Internal Medicine ,Distinguished Professor ,Boxed Warning ,Sensitive Malignancies ,Mood Disorders ,Including Depression ,Transaminase Elevations ,Cholestatic Jaundice ,Blood Pressure ,Menstrual Bleeding Pattern ,Reduced Ability ,Recognize Pregnancy ,Early Pregnancy Loss ,Fibroid Prolapse ,Lipid Metabolism ,P Gp Inhibitors ,United Kingdom Medicines ,New Drug Application ,United States Prescribing Information ,Sumitovant Biopharma ,Breakthroughs That Change Patient Lives ,Private Securities Litigation Reform Act ,Myovant Science ,United States Securities ,Myovant Science Quarterly Report ,Annual Report ,Looking Information ,Factors That May Affect Future ,Reproductive Medicine ,Human Reproduction ,Best Pract Res Clin Obstet ,Gynecol Obstet ,Nyse Myov ,Nc ,Myovant ,Healthcare ,